ArticleJournal of personalized medicine2022

VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages.

Sergey V Kulemzin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.